Casi Invest Information

Analysis
CASI Pharmaceuticals Targets Stability with 'Hold' Rating from Investment Analysts Jun 1, 2024
Stocks
CASI Pharmaceuticals Embarks on New Investment Journey with Coverage Initiation by StockNews.com Nov 13, 2023